“CUVIS-joint” of CUREXO supplied additionally to three medical institutions in Korea
“CUVIS-joint” of CUREXO supplied additionally to three medical institutions in Korea
  • 글·장인선 기자ㅣ번역·이정진 인턴기자 (insun@k-health.com)
  • 승인 2021.06.07 19:46
  • 댓글 0
이 기사를 공유합니다

As in May, 11 units are supplied domestically and internationally… expect to expand the supply by collaborating with implant companies
CUVIS-joint was recently approved by the Ministry of Food and Drug Safety last June and received the Europe CE mark in March, and is currently in preparation for the US FDA approval. The photo shows CUVIS-joint getting installed in a medical institution.
CUVIS-joint was recently approved by the Ministry of Food and Drug Safety last June and received the Europe CE mark in March, and is currently in preparation for the US FDA approval. The photo shows CUVIS-joint getting installed in a medical institution.

“CUVIS-joint,” an artificial joint surgery robot developed by CUREXO, is expected to be active in more domestic medical institutions.

CUREXO announced the successful installation of “CUVIS-joint” at Jinju Seran Hospital, Ulsan Hibone Hospital, and Yonsei Knee & Spine Hospital. This makes CUVIS-joint have a total of 11 units sold in May, including eight in Korea and three units overseas.

CUVIS-joint, developed by CUREXO using its original technology, is the first Korean artificial joint surgery robot that has been commercialized 4th in the world. It allows the artificial joint to be inserted accurately by automatically cutting bones under the supervision of surgeons.

CUVIS-joint provides a wider surgical area using a 6-axis vertical multi-joint Robot Arm that can rotate 360 degrees like a human arm and can use various implants through an open platform. The cutting range can be adjusted during surgery, providing an optimized surgery experience to patients.

According to CUREXO, Jinju Seran Hospital has performed more than 4000 robot surgeries after installing “ROBODOC,” another artificial joint surgery robot of CUREXO, in 2010. The hospital decided to install CUVIS-joint because of its superior surgical results and patients’ recovery compared to those of manual surgery.

“CUVIS-joint released in the second half of last year provided optimal surgical results to both surgeons and patients and reduced surgical errors, side effects, and probabilities for revision surgery. Many artificial joint specialists are considering installing CUVIS-joint because of these reasons,” said CEO Lee Jae Jun. “Opportunities to supply the device to artificial joint clinics will expand since characteristics of open platforms allow us to contract with major global implant companies operating in Korea as well as domestic artificial joint implant companies.”



댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.